Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...

2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the world is not on track to meet the ambitious ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

March is a significant month for women's health, observing International Women's Day and National Women's HIV/AIDS Awareness ...

PEPFAR, a global program to combat AIDS, faces an existential threat due to partisan politics, but Congress has an opportunity to reform the program and ensure its continued success.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, Marty's Place hosted an Emergency Punk and Drag Fundraiser at El Rio ...

Federal datasets began disappearing from public view on Jan 31, in response to executive orders from President Donald Trump.

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...